Editorial: Multiple Sclerosis: Pathogenesis and Therapeutics

Med Chem. 2018 Feb 6;14(2):104-105. doi: 10.2174/157340641402180206092504.

Authors

Maria Katsara¹, Vasso Apostolopoulos²

Affiliations

¹ Novartis (Hellas) SACI, Medical Department, National Road No1 (12th Km). GR-144 51, Metamorphosis-Athens, Greece.
² Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Werribee Campus, VIC 3030, Australia.

PMID: 29453907
DOI: 10.2174/157340641402180206092504

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Humans
Multiple Sclerosis / drug therapy
Multiple Sclerosis / etiology*
Multiple Sclerosis / therapy*